Sodium Houttuyfonate Ameliorates β-amyloid1-42-Induced Memory Impairment and Neuroinflammation through Inhibiting the NLRP3/GSDMD Pathway in Alzheimer's Disease. This evidence concerns the gene GSDMD and early-onset autosomal dominant Alzheimer disease.